title: Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
abstract: The INK4A/ARF locus on chromosome 9 is a tumor suppressor gene frequently mutated in human cancers. In order to study the effects of p14ARF expression in tumor cells, we constructed a recombinant adenovirus containing p14ARF cDNA (Adp14ARF). Adp14ARF infection of U2OS osteosarcoma cells which has wild type p53 and mutant p14ARF revealed high levels of p14 (ARF) expression within 24h. In addition, Adp14ARF-mediated expressing of p14 (ARF) was associated with increased levels of p53, p21, and mdm2 protein. Growth inhibition assays following Adp14ARF infection demonstrated that the growth of U2OS cells was inhibited relative to infection with control virus. Furthermore, TUNEL analysis as well as PARP cleavage assays demonstrated that Adp14ARF infection was associated with increased apoptosis in U2OS cell line and that it was associated with Adp14ARF induced overexpression of Fas and Fas-L. Addition of Fas-L neutralizing antibody NOK-1 decreased Adp14-mediated cell death, indicating that p14 (ARF) induction of the Fas pathway is associated with increased apoptosis. The finding that Adp14ARF infection did not induce Fas expression in U2OS/E6 and MCF/E6 cells suggests that wild type p53 expression may be necessary for Adp14ARF-mediated induction of Fas. The observation that overexpression of p53 by Adp53 infection in MCF-7 does not induce increased Fas protein levels nor apoptotic cell death suggests that p53 overexpression is required but not sufficient enough for apoptosis. These studies suggest there are other mechanisms other than induction of p53 in ARF-mediated apoptosis and gene therapy using Adp14ARF may be a promising treatment option for human cancers containing wild type p53 and mutant or deleted p14 expression.
authors.affiliation: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-6805, USA. minkim@cnmc.org
authors.forename: Min
authors.initials: M
authors.lastname: Kim
authors.forename: Magda
authors.initials: M
authors.lastname: Sgagias
authors.forename: Xiyun
authors.initials: X
authors.lastname: Deng
authors.forename: Yun-Jin
authors.initials: YJ
authors.lastname: Jung
authors.forename: Toshiki
authors.initials: T
authors.lastname: Rikiyama
authors.forename: Kwangmoon
authors.initials: K
authors.lastname: Lee
authors.forename: Michel
authors.initials: M
authors.lastname: Ouellette
authors.forename: Kenneth
authors.initials: K
authors.lastname: Cowan
mesh_terms: D000256:Adenoviridae / Q000235:genetics* / Q000254:growth & development; D000257:Adenoviridae Infections / Q000235:genetics* / Q000378:metabolism; D017209:Apoptosis; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D002453:Cell Cycle; D045744:Cell Line, Tumor; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D012516:Osteosarcoma / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology / Q000821:virology; D025803:Tumor Suppressor Protein p14ARF / Q000378:metabolism*; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D025803:Tumor Suppressor Protein p14ARF; D019014:fas Receptor